PROCEPT BioRobotics Q2 EPS $(0.56) Beats $(0.57) Estimate, Sales $33.10M Beat $30.46M Estimate
Portfolio Pulse from Benzinga Newsdesk
PROCEPT BioRobotics (NASDAQ:PRCT) reported Q2 losses of $(0.56) per share, beating the analyst consensus estimate of $(0.57) by 1.75%. This is a 30.23% decrease over losses from the same period last year. The company also reported quarterly sales of $33.10 million, beating the analyst consensus estimate of $30.46 million by 8.68%, a 98.33% increase over sales from the same period last year.
July 27, 2023 | 11:09 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
PROCEPT BioRobotics reported better than expected Q2 results with losses per share and sales beating analyst estimates.
PROCEPT BioRobotics reported Q2 earnings that beat analyst estimates. This is generally seen as positive news and could lead to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100